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R

ates of smoking in pregnancy
among Aboriginal and Torres
Strait Islander women are
high,1-3 with 52% smoking during
pregnancy compared with 15% in
non-Indigenous
Aus tralian
women. 3,4 Smoking during pregnancy among Aboriginal women is
inversely related to socioeconomic
status,4 and in qualitative studies,
Aboriginal women have nominated
stress as a major reason for smoking.5,6 Indigenous women in other
developed countries also have higher
rates of smoking during pregnancy
than women in the general population.7-9
As smoking rates in the general
population have fallen in highincome countries, smoking has
become more closely related to
entrenched social disadvantage.10 A
review of interventions for promoting smoking cessation during pregnancy 10 showed that intervention
was associated with a significant
overall reduction in smoking during
late pregnancy (risk ratio [RR], 0.94
[95% CI, 0.93–0.96]). The review
suggested there was a need for studies to refine interventions to address
the specific needs of disadvantaged
subpopulations.10
The aim of our study was to determine the effect of an intensive smokin g ce ss atio n i nt erve nt ion fo r
pregnant Aboriginal and Torres Strait
Islander women on smoking rates at
36 weeks’ gestation.

Methods
Setting and participants

Our study was conducted at three
The Medical Journal
of Australia
ISSN: 0025Aboriginal
community-controlled
729X 2 July 2012
197 1services
42-46 located in urban comhealth
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munities in Queensland and Western
www.mja.com.au
Australia. Pregnant Aboriginal and
Research
Torres Strait Islander women who
attended antenatal clinics at the participating health services were the target population.
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Abstract
Objective: To determine the effectiveness of an intensive quit-smoking
intervention on smoking rates at 36 weeks’ gestation among pregnant
Aboriginal and Torres Strait Islander women.
Design: Randomised controlled trial.
Setting and participants: Pregnant Aboriginal and Torres Strait Islander women
(n = 263) attending their first antenatal visit at one of three Aboriginal
community-controlled health services between June 2005 and December
2009.
Intervention: A general practitioner and other health care workers delivered
tailored advice and support to quit smoking to women at their first antenatal
visit, using evidence-based communication skills and engaging the woman’s
partner and other adults in supporting the quit attempts. Nicotine replacement
therapy was offered after two failed attempts to quit. The control (“usual care”)
group received advice to quit smoking and further support and advice by the GP
at scheduled antenatal visits.
Main outcome measure: Self-reported smoking status (validated with a urine
cotinine measurement) between 36 weeks’ gestation and delivery.
Results: Participants in the intervention group (n = 148) and usual care group
(n = 115) were similar in baseline characteristics, except that there were more
women who had recently quit smoking in the intervention group than the control
group. At 36 weeks, there was no significant difference between smoking rates
in the intervention group (89%) and the usual care group (95%) (risk ratio for
smoking in the intervention group relative to usual care group, 0.93 [95% CI,
0.86–1.08]; P = 0.212). Smoking rates in the two groups remained similar when
baseline recent quitters were excluded from the analysis.
Conclusion: An intensive quit-smoking intervention was no more effective than
usual care in assisting pregnant Aboriginal and Torres Strait Islander women to
quit smoking during pregnancy. Contamination of the intervention across
groups, or the nature of the intervention itself, may have contributed to this
result.
Trial registration: Australian New Zealand Clinical Trials Registry
ACTRN12609000929202.

Women were considered eligible to
participate in the study if they were
Aboriginal or Torres Strait Islanders;
were attending their first antenatal
appointment at one of the Aboriginal
community-controlled health services at or before 20 weeks’ gestation;
were aged 16 years or older, were
self-reported current smokers or
recent quitters (quitting when they
knew they were pregnant); and were
residents of the local area. Recent
quitters were included because there
is evidence that such women often
relapse, either later in pregnancy or
after the birth.11,12 Women were
excluded if their pregnancy was complicated by a mental illness or they
were receiving treatment for chemical
dependencies other than tobacco or
alcohol use.

Participants were recruited between
June 2005 and December 2008, with
all final follow-up sessions (between
36 weeks’ gestation and delivery)
completed by December 2009. We
were unable to report follow-up at 6
months postpartum owing to high
rates of attrition.
Women who consented to participate completed a written questionnaire recording their social and
demographic status and smoking
history.
Smoking status was determined by
asking women “Which of the following best describes your smoking status?”, with possible responses being
“re g ula r sm ok e r” , “o cc as io n al
smoker” or “quit since becoming
pregnant”. Women who smoked daily
or occasionally were asked whether

Research
they had smoked in the past 7 days.
Those who answered yes were
defined as “current smokers”. Women
who self-reported quitting since
becoming pregnant were defined as
“recent quitters”.
Randomisation
A randomised controlled design was
used. To reduce the probability of contamination by providers delivering the
intervention to both the intervention
group and the usual care group, and
to increase the ease with which health
care providers could follow the experimental protocol, randomisation was
by week of clinic attendance. An Excel
computer program was used to randomly allocate weeks to intervention
or control for all clinics. At the beginning of each week, clinics were notified of the allocation sequence and
the research assistant flagged the clinical record of study participants to
indicate whether they were allocated
to the usual care or intervention
group. The person generating the
allocation sequence was not involved
in participant recruitment. Participants were informed of the purpose of
the study at recruitment but not of
their allocated treatment group until
after they had provided consent.
Study intervention and outcome
measures

Intervention development and
principles
The intervention was developed after
a critical review of the literature and
consultation with general practitioners, health care workers and community representatives in the health
services.
Principles of the intervention were
as follows: (i) it should be culturally
sensitive and specific; (ii) the GP
would advise the women to quit
smoking by going “cold turkey”; (iii)
the GP would ask women attempting
to quit to voluntarily leave their cigarettes at the clinic before they left; (iv)
significant others (including the
woman’s partner or other adult residents of the home) would be invited
verbally and by mail to support the
woman by attempting to quit smoking
themselves and by supporting the
woman’s attempts to quit; (v) health
care workers would be encouraged to
provide evidence-based communication,

including getting written agreement
by the mother to quit, providing written instructions about strategies to
cope with cravings for a cigarette,
repeating and summarising key components of verbal quitting advice, asking the woman to recall the verbal
messages to the health care provider,
and filling in key gaps in the woman’s
recall; (vi) booster support sessions
would be scheduled to strengthen
support for women with early nicotine
withdrawal symptoms; (vii) women
who relapsed into smoking would be
asked to continue making attempts to
quit while pregnant; and (viii) nicotine
replacement therapy would be offered
to women who had failed two
attempts at quitting.
Women in the intervention group
were reassured that their care would
not alter as a consequence of smoking.
Details of the intervention
For women in the intervention group,
the intervention commenced at the
woman’s first antenatal visit, with a
scripted invitation from the doctor for
her to quit smoking (details of script
available from th e auth ors on
request). Women who agreed to stop
smoking were then advised by the
doctor to quit “cold turkey” and to
return to the clinic staff again in 3–5
days, given the pernicious nature of
smoking. The doctor also checked
whether the woman had understood
the advice, repeated any components
not understood, and gave the woman
an appointment reminder card for her
wallet, a fridge magnet and a letter for
other household members requesting
they support the woman as she
attempted to quit smoking. Women
were asked to bring a partner or support person with them on their second visit. If women indicated at the
first antenatal visit that they didn’t
want to stop smoking, the doctor
replied “I understand that it is difficult
to stop smoking. However, because it
is important, I would like to talk with
you again about it when you next visit
for antenatal care. Would that be
OK?” Women could then indicate if
they didn’t want to talk about smoking again at future antenatal visits.
Follow-up visits were scheduled at
3–5 days and 7–10 days after the first
antenatal visit to provide further support at a time when women would be

experiencing major nicotine withdrawal symptoms. For women who
were still smoking at the 7–10-day
visit, nicotine replacement therapy
was discussed and commenced for
those who had no contraindications
and wished to try it.
The initial intervention agent was
the treating GP, with follow-up conducted by female Aboriginal or Torres
Strait Islander health workers and
midwives. Training was provided on
site at each clinic at baseline and
throughout the intervention period. A
behavioural scientist and an Aboriginal doctor with GP experience provided the training.
Intervention training involved
video demonstration, role play and
presentation of relevant research literature. A study manual and a one-page
guide with scripted advice for each
participant enrolment and intervention session were provided to assist in
implementing the intervention.
Adherence to experimental
protocol
To ensure adherence to the protocol
during the study, a number of visits
were made by the lead investigators,
and intervention refresher training
was provided.
Doctors and other health care providers were also asked to complete a
checklist of the essential intervention
components after seeing each woman
in the intervention group. The health
care providers self-reported their
adherence to the protocol for a subgroup of 66 women in the intervention group.
Usual care
Women in the usual care group
received general advice from their GP
about quitting smoking, based on
existing brief intervention guidelines.13
Follow-up
Women were asked to provide the
contact details of three people who
would be able to contact them. The
women were given a written appointment date and time for their next
clinic visit. They were also phoned
and sent text messages by mobile
phone to remind them of each
appointment.
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1 Flow diagram of randomisation and recruitment of trial participants

Randomisation by week of attendance
Exclusions (n = 740)
Not Aboriginal (n = 30)
Non-smoker (n = 474)
Late gestation (n = 163)
Non-smoker and late gestation (n = 51)
Not permanent resident (n = 11)
Mental health problems (n = 11)

Antenatal patients (n = 1180)
Assessed for eligibility (n = 1119)
Eligible (n = 379)

per group) could be followed up.
This sample size for outcomes
would allow detection of a 20% difference between groups in smoking
cessation (assuming a quit rate of
15% in the control group), with 5%
significance level and 80% power,
and allowing for a design effect of
1.5 for clustering of participants
within clinics.
Consent and ethics approval

Declined to participate (n = 116)

Consented to participate (n = 263 [69%])

Usual care group (n = 115)

Intervention group (n = 148)

Lost to follow-up (n = 37)

Lost to follow-up (n = 50)

Analysed at 36-week visit (n = 78)

Analysed at 36-week visit (n = 98)

Outcome measures
Outcome assessments were conducted between 36 weeks’ gestation
and delivery. Women who reported
they had quit smoking were asked to
provide a urine sample for cotinine
analysis, and a portion of the sample
was frozen at – 20C before analysis.
A Co z a rt mi cr op la te E L IS A
(enzyme-linked immunosorbent
assay) test kit (Concateno, London,
UK) was used for urine analysis. All
samples were analysed in duplicate,
with final results based on the average
result of two paired wells. A woman
was defined at follow-up as being a
current smoker if (i) she reported that
she had smoked in the previous 7
days; (ii) she reported that she had
not smoked within the previous 7
days, but had a urine cotinine level of
⭓ 250 ng/mL at the time; or (iii) she
did not provide a urine sample.5
Statistical methods

Statistical analysis
Baseline characteristics of the two
intervention groups are presented as
frequency distributions for categorical
variables and medians and quartiles
for continuous variables. Because of
the small numbers of quitters, exact
logistic regression analyses were used
to compare 36-week smoking status
between the two groups after adjusting for recruitment centre. Relative
risks and 95% confidence intervals
were estimated using the Mantel–
Haenszel technique, with stratification by health service.
44
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The primary analysis included
women for whom follow-up data were
available. Sensitivity analysis involved
an intention-to-treat analysis, with
women who were lost to follow-up
considered as continuing smokers.
Analyses were conducted using Stata
statistical software, version 10.1 (StataCorp, College Station, Texas, USA).
Sample size justification
We planned to recruit 270 smokers
into the study over a 30-month
period (135 women in each of the
intervention and control groups). We
assumed that 80% of women (108

Eligible women were informed about
the study and invited to participate.
Non-consenters were asked their
age, marital status, number of children, address and whether they
smoked.
Our study was approved by the
University of Newcastle’s Human
Research Ethics Committee and the
Western Australian Aboriginal Health
Information and Ethics Committee.

Results
Flow of participants

A flow diagram of randomisation and
recruitment of trial participants is
shown in Box 1. Of the 263 women
who consented to participate, 148
were in the intervention group and
115 in the usual care group. Twothirds of the women (176 [67%]) completed the outcome assessment: 98
(66%) in the intervention group and
78 (68%) in the usual care group.

2 Baseline characteristics of participants in the intervention and usual care
groups*
Usual care group
(n = 115)

Intervention group
(n = 148)

Median number of cigarettes smoked per day
(interquartile range)

10.0 (4.0–15.0)

10.0 (5.0–15.0)

Median number of weeks’ gestation at
recruitment (interquartile range)

12.0 (8.0–19.0)

12.0 (8.0–17.0)

Characteristic

86 (92%)

118 (88%)

Regular smoker

73 (77%)

92 (67%)

Occasional smoker

14 (15%)

21 (15%)

8 (8%)

24 (18%)

Clinic 1

60 (52%)

86 (58%)

Clinic 2

39 (34%)

44 (30%)

Clinic 3

16 (14%)

18 (12%)

Has a partner
Smoking status

Quit since becoming pregnant
Location

Parity
0

28 (30%)

41 (30%)

1

22 (23%)

30 (22%)

2 or more

44 (47%)

66 (48%)

* Because of missing data, totals in each category vary.

◆
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3 Compliance of doctors and health workers/nurses with the intervention protocol*
Number (%)
of women who
received component

Protocol domain

Protocol component

Doctor’s compliance at first antenatal visit

Written agreement between woman and doctor to quit

47 (71%)

Advice that best way to quit was to go “cold turkey”

49 (74%)

Health worker’s or nurse’s compliance at first antenatal visit

Participant’s compliance with follow-up visits

Doctor prescribed NRT at third (7–10-day) visit

Agreement to talk again

42 (64%)

Letter sent to support person

38 (58%)

Advice about adverse effects of smoking

16 (24%)

Advice about avoiding triggers for cravings

14 (21%)

Advice about ways to cope with cravings

15 (23%)

Advice about benefits of quitting smoking

15 (23%)

Advice about multiple attempts needed to quit

11 (17%)

Advice about trying again even if relapse occurs

10 (15%)

Education pamphlets given

14 (21%)

Attended follow-up within 3–7 days

42 (64%)

Attended second follow-up at 7–10 days

23 (35%)

Prescribed NRT at third visit

21 (32%)

NRT = nicotine replacement therapy. * Expressed as number (%) of a subgroup of 66 women in the intervention group who received specific components
of the structured behavioural change intervention.
◆

Baseline characteristics

Women in both groups were similar in
terms of the median number of cigarettes smoked per day, number of
weeks’ gestation at recruitment, and
parity (Box 2). Compared with the
usual care group, a slightly higher
proportion of women in the intervention group were from Clinic 1, and a
slightly lower proportion had a partner. The intervention group had a
higher proportion of recent quitters
than the control group. Consequently,
we undertook a post-hoc subgroup
analysis that included only those
women classified as regular or occasional smokers at baseline.
Provider adherence to protocol

In over 64% of intervention consultations, doctors adhered to the protocol in
providing key components of the intervention. Lower proportions of nurses
and health workers recorded that they
had provided intervention advice (Box 3).
Trial outcomes

At 36-week follow-up, there was no
significant difference in smoking rates

between the two groups. Of the
women followed up, 87 (89%) in the
intervention group and 72 (95%) in the
usual care group were smokers (RR for
intervention versus usual care, 0.93
[95% CI, 0.86–1.08]; P = 0.212) (Box 4).
Smoking status at follow-up was
not available for two women in the
usual care group. Cotinine measures
for 16 of 34 women who self-reported
that they had quit were missing
(seven from the intervention group
and nine from the usual care group),
and a further three had cotinine levels
⭓ 250 ng/mL. These 19 women were
classified as continuing smokers.
As expected, smoking rates were
higher in the intention-to-treat analysis, with 137 smokers (93%) in the
intervention group and 111 smokers
(97%) in the usual care group (RR,
0.95 [95% CI, 0.90–1.01]; P = 0.207)
(Box 4).
Subgroup analysis excluding baseline recent quitters showed no significant differences in smoking rates
between the intervention group and
the usual care group (P = 0.992) (Box
5). Corresponding figures for the
intention-to-treat analysis were 123

smokers (99%) in the intervention
group and 105 smokers (98%) in the
usual care group (RR, 1.01 [95% CI,
0.98–1.04]; P = 0.965) (Box 5).

Discussion
At 36-week follow-up, we found no
significant difference in smoking rates
between pregnant women who
received a high-intensity quit-smoking intervention compared with those
who received usual care. To our
knowledge, ours are the first cotininevalidated quit rates reported for Aboriginal and Torres Strait Islander
women in any intervention study.
Over 70% of women in the intervention group agreed to try to quit
smoking when asked by the GP at
their first antenatal visit, and over
60% attended a visit scheduled within
3–7 days of agreeing to make this quit
attempt. These findings indicate a
high degree of willingness among
pregnant Aboriginal and Torres Strait
Islander women who smoke to
engage with quit attempts.

4 Number (%) of women smoking at ⭓ 36 weeks’ gestation, based on cotinine validation of self-report:* complete outcome
versus intention-to-treat analysis
Usual care group
Analysis of women with complete follow-up data

72/76 (95%)

Intention-to-treat analysis¶

111/115 (97%)

§

Intervention group

P†

RR (95% CI)‡

87/98 (89%)

0.212

0.93 (0.86–1.08)

137/148 (93%)

0.207

0.95 (0.90–1.01)

RR = risk ratio. * Women with a missing cotinine sample or with cotinine level ⭓ 250 ng/mL were classiﬁed as smokers. † P value for testing difference in
quit rates was calculated using exact logistic regression. P was adjusted for centre. ‡ RR (95% CI) was estimated using the Mantel–Haenszel technique.
§ Excludes two women with missing smoking status. ¶ Women lost to follow-up or with missing smoking status were classified as current smokers.
◆
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5 Number (%) of women smoking at ⭓ 36 weeks’ gestation, based on cotinine validation of self-report:* complete outcome
versus intention-to-treat analysis, excluding baseline recent quitters

Analysis of women with complete follow-up data
(excluding baseline recent quitters)
Intention-to-treat analysis¶

Usual care group

Intervention group

P†

RR (95% CI)‡

68/70 (97%)§

80/81 (99%)

0.992

1.01 (0.96–1.06)

105/107 (98%)

123/124 (99%)

0.965

1.01 (0.98–1.04)

RR = risk ratio. * Women with a missing cotinine sample or with cotinine level ⭓ 250 ng/mL were classiﬁed as smokers. † P value for testing difference
in quit rates was calculated using exact logistic regression. P was adjusted for centre. ‡ RR (95% CI) was estimated using the Mantel–Haenszel technique.
§ Excludes two women with missing smoking status. ¶ Women lost to follow-up or with missing smoking status were classified as current smokers.
◆

In our study design we estimated
that women who received the intervention would have a 20% higher
absolute quit rate than women in the
control group. We based this estimate
on the high proportion of Aboriginal
and Torres Strait Islander women who
smoked during pregnancy compared
w ith n on -Indigen ous preg nan t
women. We expected to find that a
large number of women would have
lower levels of nicotine dependence
and would be able to quit with intensive support. A previous study of Aboriginal people had shown high levels
of motivation to quit among pregnant
women compared with other adults.14
However, our expectations were not
borne out by our results.
At baseline, there were more recent
quitters in the intervention group
than the control group. Post-hoc
analysis of the subgroup of women
that excluded baseline quitters
showed that smoking rates in the
intervention and usual care groups
were more similar at follow-up than
at baseline. This suggests that most of
the non-smokers at follow-up were
those who were recent quitters at
baseline. One possible reason for this
is that, in this population, once
women quit smoking in pregnancy
they tend to remain quitters for the
duration of the pregnancy. This is
contrary to previous evidence that
women who quit smoking when they
become pregnant are likely to relapse
later in the pregnancy.11,12
Our study had a number of positive
aspects. The brief intervention was
innovative and provided a fresh focus
on smoking reduction for these services, which are accustomed to struggling with large numbers of tobacco
users.
Methodological limitations of our
study were the high (over 30%) loss to
follow-up, lack of allocation concealment, and the potential for contamination between groups (see below).
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Despite extensive efforts, we were
unable to limit the loss to follow-up.
High staff turnover increased the
difficulty of ensuring adherence to the
intervention protocol. Extensive
retraining was required during the
study. There was potential for contamination by the providers delivering
the intervention to both the intervention and usual care women. Although
we randomised by week of clinical
attendance to reduce the possibility
that providers would contaminate
groups at the initial visit, providers
were required to change their consultation approach after recruitment
according to each woman’s study allocation. Our decision to randomise by
week of attendance resulted in a lack
of allocation concealment among the
people recruiting women to the study.
The fact that more women were
recruited to the intervention group
than the usual care group may be a
result of the lack of allocation concealment.
Our study has implications for
intervention research and efforts to
reduce smoking among Aboriginal
people. Studies other than placebocontrolled drug trials that randomly
allocate individual participants to
receive interventions are likely to be
contaminated. Future studies should
c o nsid e r c lu st er ra nd o m ise d
designs.
Our study highlights some of the
difficulties of undertaking research in
this field. However, given the serious
impact of smoking in this group, continuing research and work in this area
is an urgent priority.
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